News
49mon MSN
Bioventus outlines path to $100M+ PNS revenue opportunity as new products receive clearance
Explore Bioventus’ Q2 2025 earnings highlights with 6% organic growth, PNS advancements, and reaffirmed guidance. Discover their path to revenue expansion.
LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ: LX), a leading technology-empowered personal financial service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback